|
Volumn 23, Issue 6, 2003, Pages 446-449
|
The in vitro and in vivo immunogenicity of recombinant adenovirus vaccine containing EBV-latent membrane protein 2
|
Author keywords
CTL; DC; EBV; LMP2; Recombinant adenovirus
|
Indexed keywords
LATENT MEMBRANE PROTEIN 2;
UNCLASSIFIED DRUG;
VIRUS PROTEIN;
VIRUS VACCINE;
ADENOVIRUS;
ARTICLE;
BURKITT LYMPHOMA;
CELL STIMULATION;
CELLULAR IMMUNITY;
DISEASE ASSOCIATION;
EPSTEIN BARR VIRUS;
GENE IDENTIFICATION;
GENE TARGETING;
IMMUNIZATION;
IMMUNOFLUORESCENCE TEST;
IMMUNOGENICITY;
IMMUNOLOGY;
LYMPHOCYTE;
POLYMERASE CHAIN REACTION;
PROTEIN EXPRESSION;
T LYMPHOCYTE;
VIRUS RECOMBINANT;
VIRUS RECOMBINATION;
|
EID: 0043066768
PISSN: 02545101
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (9)
|